pentoxifylline has been researched along with Diabetic Angiopathies in 37 studies
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cilostazol and pentoxifylline are the only two drugs that have been approved for the treatment of patients with intermittent claudication." | 9.09 | Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication. ( Lee, TM; Lee, YT; Su, SF; Tsai, CH; Wang, SS, 2001) |
| "Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease." | 6.44 | Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes. ( Guerrero-Romero, F; Rodríguez-Morán, M, 2008) |
| " Cilostazol and pentoxifylline are the only two drugs that have been approved for the treatment of patients with intermittent claudication." | 5.09 | Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication. ( Lee, TM; Lee, YT; Su, SF; Tsai, CH; Wang, SS, 2001) |
| "The authors analyzed the results of a 2-year study of a course of diabetic microangiopathy on the basis of clinical tests and morphological control over microvessels of skin biopsy specimens from 61 patients with diabetes mellitus, of whom 36 regularly received coronary vasodilators (diamicron, pentoxifylline and dipyridamole)." | 3.67 | [Results of a two-year clinico-morphological study of the natural evolution of diabetic microangiopathy and the efficacy of angioprotective therapy]. ( Frolova, AI; Saltykov, BB; Shubina, OI; Velikov, VK, 1987) |
| "A study was carried out in 127 patients (94 males and 33 females) presenting with arteriosclerosis (88 patients) or diabetic vasculopathy (39 patients) in different stages of severity (Fontaine) to assess the effectiveness and tolerance of treatment with high doses of pentoxifylline." | 3.67 | Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses. ( Antignani, PL; Bartolo, M; Pacino, G; Saliceti, F; Todini, AR, 1987) |
| "Pentoxifylline was administered for 6 months." | 2.76 | Effectiveness of pentoxifylline on the cross-sectional area of intima media thickness and functions of the common carotid artery in adolescents with type 1 diabetes. ( Atabek, ME; Baykara, M; Kurtoglu, S; Selver, B, 2011) |
| "Pentoxifylline treatment did not affect the plasma levels of the 3 other variables, von Willebrand factor, 6-keto prostaglandin F1 alpha and thromboxane B2." | 2.67 | Platelet activation in diabetic patients with asymptomatic atherosclerosis. ( Imano, E; Kamada, T; Kawamori, R; Kodama, M; Matsushima, H; Nishizawa, H; Watarai, T; Yamasaki, Y, 1994) |
| "Metformin has unique, intrinsic actions specifically at the level of terminal arterioles, which are completely independent of its antidiabetic effect." | 2.48 | Microvascular diseases: is a new era coming? ( Rapin, JR; Wiernsperger, N, 2012) |
| "Among the microvascular complications, diabetic nephropathy is the most frequent cause of end-stage renal disease." | 2.44 | Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes. ( Guerrero-Romero, F; Rodríguez-Morán, M, 2008) |
| "Pentoxifylline was used in the treatment of 90 patients with atherosclerosis-induced chronic peripheral arterial occlusive disease and diabetic vascular disorders in the lower extremities (clinical Fontaine Stages III and IV) for whom surgical reconstructive treatment was not indicated and who had shown inadequate response to previous therapy." | 1.27 | Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease. ( Seige, K; Sternitzky, R, 1985) |
| "A long-term trial with oral pentoxifylline ("Trental" 400) in a dosage of 1200 mg per day was carried out in 70 diabetic patients with and without vascular afflictions." | 1.27 | Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline. ( Ferrari, E; Solerte, SB, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (64.86) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 4 (10.81) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atabek, ME | 1 |
| Kurtoglu, S | 1 |
| Selver, B | 1 |
| Baykara, M | 1 |
| Wiernsperger, N | 1 |
| Rapin, JR | 1 |
| Rodríguez-Morán, M | 1 |
| Guerrero-Romero, F | 1 |
| Lipsitz, EC | 1 |
| Kim, S | 1 |
| Saldan, IR | 1 |
| Campbell, RK | 2 |
| Baker, DE | 1 |
| Moratti, F | 1 |
| Cortiana, M | 1 |
| Taglioretti, D | 1 |
| Petruzzi, E | 1 |
| Bucalossi, A | 1 |
| Corri, S | 1 |
| Marsilii, A | 1 |
| Di Noto, C | 1 |
| Valentini, M | 1 |
| Sciannameo, F | 1 |
| Francucci, M | 1 |
| Tockner, M | 1 |
| Sassano, L | 1 |
| Allegra, A | 1 |
| Isogai, Y | 1 |
| Mochzuki, K | 1 |
| Maeda, T | 1 |
| Spesivtseva, VG | 1 |
| Kasabian, IN | 1 |
| Mamaeva, GG | 1 |
| Kukes, VG | 1 |
| Fossati, C | 1 |
| Pampulov, L | 2 |
| Todorova, S | 1 |
| Vogralik, VG | 1 |
| Vogralik, MV | 1 |
| Runov, GP | 1 |
| Runova, AA | 1 |
| Kostrov, AI | 1 |
| Kawamori, R | 1 |
| Imano, E | 1 |
| Watarai, T | 1 |
| Nishizawa, H | 1 |
| Matsushima, H | 1 |
| Kodama, M | 1 |
| Yamasaki, Y | 1 |
| Kamada, T | 1 |
| Colen, LB | 1 |
| Stevenson, A | 1 |
| Sidorov, V | 1 |
| Potparic, Z | 1 |
| Pacelli, E | 1 |
| Searles, J | 1 |
| Lee, S | 1 |
| Li, L | 1 |
| Solerte, SB | 3 |
| Fioravanti, M | 2 |
| Cerutti, N | 1 |
| Severgnini, S | 1 |
| Locatelli, M | 1 |
| Pezza, N | 1 |
| Rondanelli, M | 1 |
| Trecate, L | 1 |
| Balza, G | 1 |
| Ferrari, E | 3 |
| McDaniel, MD | 1 |
| James, SH | 1 |
| Meyers, AM | 1 |
| McCarty, MF | 1 |
| Bonnardel-Phu, E | 1 |
| Vicaut, E | 1 |
| Lee, TM | 1 |
| Su, SF | 1 |
| Tsai, CH | 1 |
| Lee, YT | 1 |
| Wang, SS | 1 |
| Kolarov, P | 1 |
| Veleva, N | 1 |
| Nobbe, F | 1 |
| Schubotz, R | 1 |
| Mühlfellner, O | 1 |
| Schwartz, RW | 1 |
| Logan, NM | 1 |
| Johnson, PJ | 1 |
| Strodel, WE | 1 |
| Fine, JG | 1 |
| Kazmers, A | 1 |
| Hyde, GL | 1 |
| Jarcusková, D | 1 |
| Uhrík, J | 1 |
| Nazarova, KhI | 1 |
| Gómez Reyes, D | 2 |
| Rojas Hidalgo, E | 2 |
| Velikov, VK | 1 |
| Shubina, OI | 1 |
| Saltykov, BB | 1 |
| Frolova, AI | 1 |
| Patti, AL | 1 |
| Viola, C | 1 |
| Antignani, PL | 1 |
| Todini, AR | 1 |
| Saliceti, F | 1 |
| Pacino, G | 1 |
| Bartolo, M | 1 |
| David, JS | 1 |
| Reichle, RM | 1 |
| Reichle, FA | 1 |
| Sternitzky, R | 1 |
| Seige, K | 1 |
5 reviews available for pentoxifylline and Diabetic Angiopathies
| Article | Year |
|---|---|
Microvascular diseases: is a new era coming?
Topics: Diabetic Angiopathies; Hemorheology; Humans; Metformin; Microcirculation; Microvessels; Myocardial I | 2012 |
Efficacy of pentoxifylline in the management of microalbuminuria in patients with diabetes.
Topics: Albuminuria; Animals; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Glomeru | 2008 |
[Therapy of diabetic angiopathies].
Topics: Acetylcholine; Adrenal Cortex Hormones; Anti-Bacterial Agents; Diabetic Angiopathies; Fibrinolytic A | 1981 |
Clinical update on pentoxifylline therapy for diabetes-induced peripheral vascular disease.
Topics: Clinical Trials as Topic; Diabetes Complications; Diabetic Angiopathies; Diabetic Foot; Female; Huma | 1993 |
Clinical considerations and treatment of diabetic angiopathy.
Topics: Adult; Arterial Occlusive Diseases; Coronary Disease; Diabetic Angiopathies; Humans; Intermittent Cl | 1979 |
6 trials available for pentoxifylline and Diabetic Angiopathies
| Article | Year |
|---|---|
Effectiveness of pentoxifylline on the cross-sectional area of intima media thickness and functions of the common carotid artery in adolescents with type 1 diabetes.
Topics: Adolescent; Carotid Artery Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Child; | 2011 |
[Erythrocyte filterability and treatment with pentoxifylline].
Topics: Diabetes Mellitus, Type 1; Diabetic Angiopathies; Erythrocytes; Humans; Middle Aged; Oxygen Consumpt | 1983 |
[Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].
Topics: Adult; Aged; Blood; Clinical Trials as Topic; Diabetic Angiopathies; Diabetic Nephropathies; Female; | 1980 |
Platelet activation in diabetic patients with asymptomatic atherosclerosis.
Topics: Aged; Arteriosclerosis; beta-Thromboglobulin; Blood Pressure; Carotid Arteries; Carotid Artery Disea | 1994 |
Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
Topics: Aged; Cilostazol; Diabetic Angiopathies; Double-Blind Method; Endothelial Growth Factors; Exercise T | 2001 |
[Therapeutic effect of Trental in diabetic angiopathy].
Topics: Adult; Aged; Clinical Trials as Topic; Diabetic Angiopathies; Drug Evaluation; Electrocardiography; | 1978 |
26 other studies available for pentoxifylline and Diabetic Angiopathies
| Article | Year |
|---|---|
Antithrombotic therapy in peripheral arterial disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Cilostazol; Clopidogrel; Comorbidity; Diabetic Angiopathie | 2008 |
[Use of disaggregants in treating diabetic retinopathy].
Topics: Ascorbic Acid; Aspirin; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Dipyridamol | 1984 |
Trental: a new medication for diabetic peripheral vascular disorders.
Topics: Diabetic Angiopathies; Humans; Pentoxifylline; Theobromine | 1984 |
[Use of erythrocyte filtration in the study of diabetic vasculopathy. Therapeutic efficacy of pentoxifylline].
Topics: Diabetic Angiopathies; Erythrocyte Aggregation; Erythrocytes; Female; Filtration; Humans; Male; Pent | 1983 |
[Use of pentoxifylline in diabetes with intermittent claudication].
Topics: Cholesterol; Diabetic Angiopathies; Erythrocytes; Fibrinogen; Glycated Hemoglobin; Humans; Intermitt | 1983 |
Red cell filterability in diabetes.
Topics: Adult; Diabetes Mellitus; Diabetic Angiopathies; Erythrocyte Membrane; Erythrocytes; Hemoglobin A; H | 1981 |
[Treatment of diabetic angiopathy with pentoxifylline].
Topics: Adult; Aged; Amputation, Surgical; Diabetic Angiopathies; Female; Humans; Leg; Male; Middle Aged; Pe | 1982 |
[Trental treatment of microcirculatory disorders in diabetes mellitus and arteriosclerosis].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Blood Viscosity; Diabetic Angiopathies; Drug Evaluation; | 1982 |
Microvascular anastomotic thrombosis in experimental diabetes mellitus.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Angiopathie | 1997 |
Retrospective analysis of long-term hemorheologic effects of pentoxifylline in diabetic patients with angiopathic complications.
Topics: Adult; Aged; Albuminuria; Blood Pressure; Blood Viscosity; Diabetic Angiopathies; Female; Fibrinogen | 1997 |
A 52-year-old woman with diabetes and claudication.
Topics: Coronary Disease; Decision Making; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephro | 1998 |
Microangiopathic hemolytic anemia as a complication of diabetes mellitus.
Topics: Anemia, Hemolytic; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Erythro | 1998 |
Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy--preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline.
Topics: Animals; Antioxidants; Chromium; Diabetic Angiopathies; Diabetic Neuropathies; Diabetic Retinopathy; | 1998 |
[Role of oxidative stress in permeability changes observed in the microcirculation of diabetic rats in vivo].
Topics: Animals; Capillary Permeability; Catalase; Diabetes Mellitus, Experimental; Diabetic Angiopathies; D | 2000 |
The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane.
Topics: Aged; Diabetic Angiopathies; Erythrocyte Membrane; Erythrocytes; Fatty Acids; Female; Humans; Male; | 1977 |
Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients.
Topics: Arteries; Arteriosclerosis; Diabetes Mellitus; Diabetic Angiopathies; Exercise Test; Female; Humans; | 1989 |
[Evaluation of thermal conductivity and skin temperature in the treatment of leg ulcers].
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Diabetic Angiopathies; Female; Humans; Leg; Leg Ul | 1988 |
[Effect of the long-term prophylactic use of trental on cerebral blood flow in diabetics].
Topics: Adult; Cerebrovascular Disorders; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Diabet | 1988 |
[Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].
Topics: Adult; Aged; Diabetic Angiopathies; Drug Therapy, Combination; Female; Humans; Intermittent Claudica | 1988 |
[Results of a two-year clinico-morphological study of the natural evolution of diabetic microangiopathy and the efficacy of angioprotective therapy].
Topics: Adolescent; Adult; Aged; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Dipyridam | 1987 |
Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients.
Topics: Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephrop | 1987 |
Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses.
Topics: Aged; Arteriosclerosis; Blood Pressure; Diabetic Angiopathies; Erythrocyte Deformability; Female; Hu | 1987 |
[Xanthinic derivatives in the treatment of intermittent claudication syndrome in diabetic patients].
Topics: Diabetes Complications; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Intermittent Claud | 1986 |
Altered low density lipoproteins in peripheral vascular disease patients.
Topics: Aged; Arterial Occlusive Diseases; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Angiopathies | 1986 |
Clinical investigation of the effects of pentoxifylline in patients with severe peripheral occlusive vascular disease.
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mell | 1985 |
Diabetic retinal vascular complications and erythrocyte filtrability; results of a 2-year follow-up study with pentoxifylline.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopath | 1985 |